Post

Zydus Cadila Wins Pharma Patent Lawsuit in the U.S.

Zydus Cadila Wins Pharma Patent Lawsuit in the U.S.

The U.S. Court of Appeals for the Federal Circuit has affirmed judgement in favor of Zydus Pharmaceuticals (USA) Inc., holding that its proposed generic version of Lialda does not infringe a U.S. Patent. Zydus is the first pharmaceutical company to file an abbreviated new drug application for a generic version of mesalamine in the U.S.

Zydus Cadila chairman and managing director Pankaj R. Patel said, “We welcome this decision which is a positive step and will help us further our mission of making available high-quality, affordable generic products to our customers and their patients.”

zydus logo

Shire Plc., a Jersey-registered, Irish-headquartered global specialty bio-pharmaceutical company reported an annual sales of $714 million for this product in 2016 in the United States, reports the Economic Times.
Share

About Amritt

Who We Are

Small or big, your business will love our financial help and business consultations! We are happy when our clients are too… Actually, this is quite simple to achieve – because each time we help them in sorting out different accounting intricacies or save the day before filing the taxes, they are happy indeed! And so are we.   

We have over Twenty years of experience helping our clients succeed in India

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Blog
Page
Dictionary
Comparisons
Capabilities
India Business Guide
Services
Private
Speaking
Insights
White Papers
News
Newsletters
Clients
Case Studies
Companies In India
Webinars
Presentations
Industries